Nita Radhakrishnan: Discussing Risks, Benefits, and Uncertainties in Hemoglobinopathy Care
Nita Radhakrishnan, Additional Professor and HOD of Pediatric Hematology-Oncology at Post Graduate Institute of Child Health, shared TIF‘s post on LinkedIn:
“Shared Decision Making in Hemoglobinopathy care
– Looking forward to discussing the risks, benefits, uncertainties, and vulnerabilities of treatment options in every day practice –
30 June 2026 Thalassaemia International Federation (TIF) Webinar Series”
Thalassaemia International Federation (TIF) shared a post on LinkedIn:
“On 30 June 2026, the TIF Webinar Series returns with a conversation that places partnership at the centre of haemoglobinopathy care:
‘Shared Decisions, Better Outcomes: Collaborative Care in Thalassaemia and SCD‘
From everyday care to newer therapeutic options, people living with Thalassaemia and Sickle Cell Disease deserve information they can understand, space to ask questions, and a genuine role in decisions that affect their lives.
Moderated by Mr. Frank Somma, Advocate and Community Leader in Haemoglobin Disorders, this 90-minute webinar brings together distinct yet equally essential voices:
- Dr. Ioanna Ampati — Principal Psychologist and Lead for Haemoglobin Disorders Psychology Service, NHS London, UK
- Ms. Shakeela Bashir Ahmed — Administrative Officer, Emirates Thalassaemia Society, UAE, and an adult living with beta thalassaemia major
- Dr. Nita Radhakrishnan — Additional Professor and Head of the Department of Pediatric Hematology-Oncology, India
- Ms. Nadia Nihat — Mother, caregiver, and patient advocate, UK
In a candid, practical exchange, the panel will discuss what it takes to turn consultation into genuine collaboration.
Join us on 30 June 2026, at 19:00 EEST (Cyprus time) / 12:00 New York time, for this important discussion on Zoom.
The TIF Webinar Series 2026 on effective health communication is supported by Bristol Myers Squibb (BMS), Agios Pharmaceuticals, and Avanzanite Bioscience.”
Other posts featuring Nita Radhakrishnan on Hemostasis Today.
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge
-
Sep 29, 2026, 16:18Edward Lee Carter: Why Periprocedural DOAC Guidance Needs a Common Output Standard
-
Sep 29, 2026, 16:07Yasmine Laraba: Deep Vein Thrombosis Causes, Signs and Management